Investors Alert: Microvast Holdings Faces Class Action Lawsuit Amid Major Losses

Microvast Holdings Investors Face Major Legal Developments

Microvast Holdings, Inc. has recently come under scrutiny following a class action lawsuit filed against it by investors who experienced financial losses over the past year. The action, announced by Levi & Korsinsky, LLP, involves allegations that the company’s leadership misled shareholders about its performance, which ultimately led to a sharp decline in the stock value. During the Class Period, spanning from April 1, 2025, to March 16, 2026, Microvast’s stock plummeted by 34.2%, wiping out substantial investor capital.

The lawsuit alleges that certain high-ranking officials at Microvast had substantial control over the company's public statements and disclosures. This includes its Founder and CEO, Yang Wu, and several former Chief Financial Officers, who supposedly misrepresented the company's financial health and growth prospects. Investors are encouraged to act promptly as there is a deadline for seeking lead plaintiff status by September 21, 2026.

Background of the Case

As detailed in the complaint, the decline in Microvast’s stock price appears to stem from several factors linked to corporate communication failures. The lawsuit contends that misleading statements were made regarding the company’s gross margin targets, the progress of its Huzhou Phase 3.2 expansion, and issues surrounding inventory management. When the truth about these operational challenges emerged, the company faced a dismal Q4 2025 revenue report and a significant margin collapse, consequently affecting investor confidence.

Allegations of Control and Misrepresentation

The heart of the allegations revolves around the assertion that Microvast’s executives had the ability to control what was disclosed in public communications. Plaintiffs claim these individuals would have been aware of the inaccuracies in statements regarding the company’s performance capabilities. By continuing to assure investors of high growth potential despite underlying issues, the executives allegedly violated their obligations to be truthful and transparent in their statements.

Additionally, the class action points to the Securities Exchange Act’s Section 20(a), indicating that the executives' control over public messaging resulted in misleading investors, leading to their eventual financial injuries. The complaint argues that the timing of the company's disclosures coincided with the damaging information coming to light and that the company's stock price fell sharply as a result.

What Should Affected Investors Do?

Investors who purchased Microvast securities during the specified period and suffered losses are encouraged to gather relevant documentation to determine their eligibility for the class action. This would typically include brokerage statements, trade confirmations, and any records of shares sold at a loss. Participation in the lawsuit is contingent on a series of legal evaluations to determine documented losses during the Class Period. Importantly, investors who sold their shares before the lawsuit was announced may still be eligible to recover losses.

One pivotal aspect of this case is the appointment of a lead plaintiff, who will represent the collective defense of the interested shareholders in court. Lead plaintiffs are often those with the most substantial losses and take a more active role in overseeing the case's progress.

Legal Representation and Next Steps

Individuals impacted by the downturn in Microvast's stock are urged to consult with legal professionals to understand their rights and options for recovery. Levi & Korsinsky, LLP, the firm involved in the lawsuit, offers a complementary assessment of investor losses and eligibility analysis. Interested parties can contact the firm directly for assistance in joining the lawsuit.

By bringing these allegations to light, affected investors hope to hold Microvast accountable for its purported mismanagement and lack of transparency. This case highlights the critical importance of accurate corporate disclosures — as shareholders rely on truthful information to make informed investment decisions.

Investors and potential suit participants are reminded to stay informed about the lawsuit's developments and act swiftly to protect their legal rights.